引用次数
引用: 8,352
H-指数: 39
I10-指数 : 68
出版物: 163
A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).
Aparna Raj Parikh , Jeffrey William Clark , Jennifer Yon-Li Wo , Beow Y Yeap
Journal of Clinical Oncology 37 3514 -3514
8
2019
CpG island methylator phenotype (CIMP) and outcome differences for African Americans (AA) and Caucasians (C) treated with FOLFOX4 or the combination with bevacizumab (B) in patients (pts) with metastatic colorectal cancer (MCRC): Results from the Eastern Cooperative Oncology Group study E3200.
Edith P. Mitchell , Paul J. Catalano , Bruce J. Giantonio , Peter J. O'Dwyer
Journal of Clinical Oncology 32 3605 -3605
2014
Final analysis: Randomized, blinded, placebo-controlled phase II trial of sorafenib with and without mapatumumab in patients with advanced hepatocellular carcinoma (HCC).
Tudor-Eliade Ciuleanu , Igor Bazin , Dan Lungulescu , Lucian Miron
Journal of Clinical Oncology 32 4029 -4029
1
2014
Racial disparities in colon cancer survival: a matched cohort study.
Jeffrey H. Silber , Paul R. Rosenbaum , Richard N. Ross , Bijan A. Niknam
Annals of Internal Medicine 161 ( 12) 845 -854
71
2014
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes
Ben Boursi , Brian Finkelman , Bruce J. Giantonio , Kevin Haynes
Gastroenterology 152 ( 4) 840 -850.e3
63
2017
Phase II pharmacodynamic trial of palbociclib in patients with KRAS mutant colorectal cancer.
Mark H. O'Hara , Christine Edmonds , Michael Farwell , Rodolfo F. Perini
Journal of Clinical Oncology 33 626 -626
7
2015
Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.
Al Bowen Benson , Fengmin Zhao , Neal J. Meropol , Paul J. Catalano
Journal of Clinical Oncology 34 3616 -3616
4
2016
Lower rates of acute gastrointestinal toxicity with pencil beam proton therapy relative to IMRT in neoadjuvant chemoradiation for rectal cancer.
Sonny Batra , Lauren Comisar , John Nicholas Lukens , Maura Kirk
Journal of Clinical Oncology 33 696 -696
2
2015
Efficacy and safety of bevacizumab in metastatic colorectal cancer (mCRC): Pooled analysis from randomized controlled trials (RCTs).
Niall Christopher Tebbutt , Herbert Hurwitz , Fairooz Kabbinavar , Bruce J Giantonio
Journal of Clinical Oncology 30 3614 -3614
2012
A phase II trial of gemcitabine, irinotecan, and panitumumab in advanced cholangiocarcinoma, with correlative analysis of EGFR, KRAS, and BRAF: An interim report.
Davendra Sohal , Ursina R. Teitelbaum , Takeshi Uehara , Kristine Mykulowycz
Journal of Clinical Oncology 30 4111 -4111
1
2012
Racial disparities in breast cancer survival.
Jeffrey H. Silber , Paul R. Rosenbaum , Amy Sanders Clark , Min Wang
Journal of Clinical Oncology 30 ( 15_suppl) 6000 -6000
1
2012
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignancies.
Joshua H. Bilenker , James P. Stevenson , Keith T. Flaherty , Kenneth Algazy
Cancer Chemotherapy and Pharmacology 53 ( 4) 357 -360
2
2004
Phase II trial of palbociclib in patients with advanced esophageal or gastric cancer.
Thomas Benjamin Karasic , Mark H. O'Hara , Ursina R. Teitelbaum , Nevena Damjanov
Journal of Clinical Oncology 36 68 -68
6
2018
A new look at the IDEA classification: Defining novel predictive and prognostic markers in stage III colon cancer.
Ofer Margalit , Ronac Mamtani , Yu-Xiao Yang , Kim Anna Reiss
Journal of Clinical Oncology 36 845 -845
2018
Concurrent RT with 5-FU/epirubicin and cisplatin or irinotecan for locally advanced upper GI adenocarcinoma
Daniel Haller , Bruce Giantonio , Richard Whittington , Maryann Gallagher
Oncology 18 ( 14) 39 -42
1
2004
Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer.
Peter J O'Dwyer , Maryann Redlinger , Daniel Haller , Bruce Giantonio
Clinical Cancer Research 8 ( 10) 3100 -3104
15
2002
Abstract LB-257: Liquid biopsy versus tissue biopsy to assess acquired resistance and tumor heterogeneity in gastrointestinal cancers
David P. Ryan , Colin D. Weekes , Eunice L. Kwak , Jason E. Faris
Cancer Research
2019
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients with New-Onset Diabetes Mellitus
Ben Boursi , Brian Finkelman , Bruce Giantonio , Kevin Haynes
Gastroenterology 152 ( 5)
2017
The Continuum of Care in Chemotherapy Approach to Metastatic Colorectal Cancer
Jenia Jenab-Wolcott , Bruce Giantonio
Current Colorectal Cancer Reports 9 ( 3) 230 -241
1
2013
Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?
Ofer Margalit , Ronac Mamtani , Yaacov R Lawrence , Yu-Xiao Yang
Molecular and Clinical Oncology 10 ( 5) 555 -559
2
2019